Adial Pharmaceuticals Lead Candidate For Alcohol Use Disorder Advances Toward Phase 3 Trial

Why did the Air India Boeing 787 crash happen? How will Trump's tariff threats impact the dollar? What caused Oracle's stock to hit a record high? Why was Sen. Alex Padilla forcibly removed at DHS press conference? How will JetZero's factory affect North Carolina jobs? Why is Google Cloud experiencing widespread outages? How is Trump's blocking of California's EV mandate affecting the market?

Adial Pharmaceuticals Lead Candidate For Alcohol Use Disorder Advances Toward Phase 3 Trial

benzinga.com/news/health-care/25/06/45880109/exclusive-adial-pharmaceuticals-lead-candidate-for-alcohol-use-disorder-advances-toward-phase-3-

Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) on Wednesday announced progress in the design and planning of its upcoming Phase 3 trial evaluating AD04, the company's lead investigational genetically targeted, serotonin-3 receptor antagonist, a therapeutic agent for Alcohol Use Disorder (AUD)…

This story appeared on benzinga.com, 2025-06-11 11:30:44.